Suppr超能文献

骨质疏松症作为泰国痴呆症潜在的可改变风险因素:一项横断面分析。

Osteoporosis as a Potential Modifiable Risk Factor for Dementia in Thailand: A Cross-Sectional Analysis.

作者信息

Hiri-O-Tappa Parit, Lawongsa Kasidid, Kengpanich Supatcha, Srisuwan Patsri

机构信息

Family Medicine, Phramongkutklao Hospital, Bangkok, THA.

Geriatrics, Phramongkutklao Hospital, Bangkok, THA.

出版信息

Cureus. 2024 Jun 30;16(6):e63511. doi: 10.7759/cureus.63511. eCollection 2024 Jun.

Abstract

OBJECTIVE

This study aims to explore the potential of osteoporosis as a modifiable risk factor for dementia and investigate whether treatments like estrogen supplementation and bisphosphonates can reduce the risk of dementia in the Thai population. This study aimed to evaluate the risk of dementia in patients with osteoporosis.

MATERIALS AND METHODS

A cross-sectional analysis was conducted. Participants aged <50 years and those with a history of dementia at baseline were excluded. Clinical variables were analyzed using the chi-squared test. Logistic regression analysis was conducted to determine independent factors of dementia after adjusting for potential confounders.

RESULTS

The cohort was conducted on 54,399 participants, of whom 9763 (17.9%) had osteoporosis. The results indicated that individuals with osteoporosis had an odds ratio (OR) of 1.62-fold higher risk of developing dementia compared to those without osteoporosis (95% confidence interval (CI) 1.37-1.92, p-value < 0.001). Furthermore, compared to patients with osteoporosis not undergoing any treatment, those receiving estrogen supplementation and bisphosphonate treatment showed reduced associations with dementia, with an OR of 0.84 (95% CI 0.73-0.98, p-value = 0.023) and 0.66 (95% CI 0.60-0.73, p-value < 0.001), respectively.

CONCLUSION

The study findings suggest an elevated risk of dementia in patients with osteoporosis and contribute substantially to our understanding of the link between osteoporosis and dementia in the Thai population.

摘要

目的

本研究旨在探讨骨质疏松症作为痴呆症可改变风险因素的可能性,并调查雌激素补充剂和双膦酸盐等治疗方法是否能降低泰国人群患痴呆症的风险。本研究旨在评估骨质疏松症患者患痴呆症的风险。

材料与方法

进行横断面分析。排除年龄小于50岁的参与者以及基线时有痴呆症病史的参与者。使用卡方检验分析临床变量。进行逻辑回归分析以确定在调整潜在混杂因素后痴呆症的独立因素。

结果

该队列研究共纳入54399名参与者,其中9763人(17.9%)患有骨质疏松症。结果表明,与未患骨质疏松症的人相比,患有骨质疏松症的人患痴呆症的风险高出1.62倍(95%置信区间(CI)为1.37 - 1.92,p值<0.001)。此外,与未接受任何治疗的骨质疏松症患者相比,接受雌激素补充剂和双膦酸盐治疗的患者与痴呆症的关联降低,其比值比(OR)分别为0.84(95% CI 0.73 - 0.98,p值 = 0.023)和0.66(95% CI 0.60 - 0.73,p值<0.001)。

结论

研究结果表明骨质疏松症患者患痴呆症的风险升高,并极大地有助于我们理解泰国人群中骨质疏松症与痴呆症之间的联系。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c7cc/11288215/ecc59985551e/cureus-0016-00000063511-i01.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验